Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $145,122,652.45
- Nov. 6, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 1, 2021 | COO | 10,515 | $11.32 | Sell | $119,029.80 | |
Oct. 15, 2021 | CEO | 22,000 | $11.22 | Sell | $246,840.00 | |
Oct. 1, 2021 | Director | 1,500 | $9.56 | Buy | $14,340.00 | |
Oct. 1, 2021 | COO | 10,515 | $10.00 | Sell | $105,150.00 | |
Oct. 1, 2021 | CEO | 7,500 | $10.00 | Sell | $75,000.00 | |
Sept. 15, 2021 | CEO | 22,000 | $11.08 | Sell | $243,760.00 | |
Sept. 3, 2021 | CEO | 5,238 | $12.02 | Sell | $62,960.76 | |
Sept. 3, 2021 | Insider | 4,925 | $12.01 | Sell | $59,149.25 | |
Sept. 1, 2021 | COO | 10,515 | $11.50 | Sell | $120,922.50 | |
Sept. 1, 2021 | CEO | 7,500 | $11.50 | Sell | $86,250.00 | |
Sept. 1, 2021 | Director | 1,500 | $11.41 | Buy | $17,115.00 | |
Aug. 23, 2021 | Insider | 5,045 | $11.00 | Sell | $55,495.00 | |
Aug. 16, 2021 | CEO | 22,000 | $10.27 | Sell | $225,940.00 | |
Aug. 5, 2021 | CEO | 37,000 | $10.03 | Sell | $371,110.00 | |
Aug. 5, 2021 | COO | 21,028 | $10.02 | Sell | $210,700.56 | |
Aug. 2, 2021 | Director | 1,500 | $9.28 | Buy | $13,920.00 | |
July 12, 2021 | CEO | 14,885 | $9.31 | Sell | $138,579.35 | |
July 1, 2021 | Director | 1,500 | $9.60 | Buy | $14,400.00 | |
June 15, 2021 | CEO | 22,000 | $10.26 | Sell | $225,720.00 | |
June 7, 2021 | CEO | 29,500 | $10.01 | Sell | $295,295.00 | |
June 7, 2021 | COO | 10,514 | $10.01 | Sell | $105,245.14 | |
June 1, 2021 | Director | 1,500 | $9.24 | Buy | $13,860.00 | |
May 25, 2021 | Director | 28,605 | $8.74 | Buy | $250,007.70 | |
May 3, 2021 | COO | 10,514 | $10.27 | Sell | $107,978.78 | |
May 3, 2021 | Director | 10,000 | $10.27 | Sell | $102,700.00 | |
May 3, 2021 | CEO | 7,500 | $10.28 | Sell | $77,100.00 | |
April 22, 2021 | CEO | 7,683 | $10.01 | Sell | $76,906.83 | |
April 15, 2021 | CEO | 22,000 | $10.09 | Sell | $221,980.00 | |
April 1, 2021 | CEO | 7,500 | $10.00 | Sell | $75,000.00 | |
April 1, 2021 | Director | 1,500 | $10.00 | Buy | $15,000.00 | |
April 1, 2021 | COO | 10,514 | $10.03 | Sell | $105,455.42 | |
March 22, 2021 | CEO | 7,682 | $10.29 | Sell | $79,047.78 | |
March 15, 2021 | CEO | 22,000 | $10.77 | Sell | $236,940.00 | |
Jan. 20, 2021 | CEO | 50,000 | $21.51 | Sell | $1,075,500.00 | |
Jan. 15, 2021 | CEO | 22,000 | $22.24 | Sell | $489,280.00 | |
Jan. 4, 2021 | CEO | 7,500 | $22.17 | Sell | $166,275.00 | |
Jan. 4, 2021 | Director | 1,500 | $23.17 | Buy | $34,755.00 | |
Jan. 4, 2021 | COO | 10,514 | $22.17 | Sell | $233,095.38 | |
Dec. 21, 2020 | CFO | 5,000 | $24.09 | Sell | $120,450.00 | |
Dec. 15, 2020 | CEO | 22,000 | $23.91 | Sell | $526,020.00 | |
Dec. 14, 2020 | Insider | 111,125 | $23.88 | Sell | $2,653,665.00 | |
Dec. 1, 2020 | Director | 1,500 | $23.50 | Buy | $35,250.00 | |
Dec. 1, 2020 | COO | 24,783 | $22.77 | Sell | $564,308.91 | |
Dec. 1, 2020 | CEO | 7,500 | $22.77 | Sell | $170,775.00 | |
Nov. 4, 2020 | Insider | 5,931 | $20.00 | Sell | $118,620.00 | |
Nov. 2, 2020 | CEO | 33,875 | $17.87 | Sell | $605,346.25 | |
Nov. 2, 2020 | Director | 1,500 | $18.01 | Buy | $27,015.00 | |
Nov. 2, 2020 | COO | 24,782 | $17.87 | Sell | $442,854.34 | |
Oct. 9, 2020 | Insider | 193,700 | $15.03 | Sell | $2,911,311.00 | |
Oct. 1, 2020 | CEO | 29,900 | $14.02 | Sell | $419,198.00 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.